MedPath

An exploratory study of administration of colistin for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.

Not Applicable
Conditions
multidrug-resistant Pseudomonas aeruginosa infections in patients with hematological disease.
Registration Number
JPRN-UMIN000002122
Lead Sponsor
niversity of Tokyo Hospital Department of Hamatology and Oncology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

1. Allergy for colistin 2. A woman who is pregnant or has chance to be pregnant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A clinical response at the end of colistin therapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath